MCLEAN, Va., May 23, 2019 /PRNewswire/ -- Clearsight
Advisors, Inc. ("Clearsight") is pleased to announce another
successful transaction in its market-leading Healthcare Consulting
Practice. Clearsight served as the exclusive strategic and
financial advisor to Putnam Associates in its acquisition by UDG
Healthcare plc's Ashfield Communications and Advisory business
(LON: UDG) ("UDG"). This transaction further emphasizes
Clearsight's position as the leader in advising high-end consulting
firms serving the life sciences and broader healthcare
industries.
Based in Boston, Putnam
Associates is a consultancy focused on product commercialization
strategy exclusively for the life sciences industry. Founded in
1988, Putnam Associates has served global biopharmaceutical,
diagnostics, and medical device clients, along with private equity
and venture capital clients, providing world-class strategic advice
based on sophisticated, robust analytics. With 120 employees
between Boston and San Francisco, Putnam Associates attracts top
talent from leading US universities and has become a respected
advisory brand for biopharmaceutical companies.
Remco op den Kelder, Partner at Putman Associates, commented,
"We chose Clearsight because of their deep focus on consulting and
their experience in the life sciences domain. We soon realized that
the team had taken the time to learn our business inside and out
and understood it as well as, if not better than, we did. Most
importantly, while the Clearsight senior team provided fantastic
advice and counsel throughout the process, it was the junior team
that truly distinguished itself with 24/7 availability and
willingness to constantly go the extra mile and explain, in detail,
the various steps to me and my partners. It's not every day that
you get to sell a business, but if we were to do so again, I would
definitely want the Clearsight team on our side."
UDG is a leading provider of commercial, clinical,
communications, and packaging services to the healthcare industry.
UDG's Ashfield division is a
global leader in commercialization services for the pharmaceutical
and healthcare industry, operating across three areas of activity:
advisory, communication, commercial & clinical services.
Putnam adds significant capabilities to Ashfield's existing advisory pillar in the US
as well as complements Ashfield's
existing advisory offering, including STEM, Vynamic, and
SmartAnalyst, which were acquired between 2016 and 2018.
Greg Treger, Co-Founder and
Managing Partner of Clearsight Advisors, said of the transaction,
"We are delighted to have represented Putnam Associates throughout
the acquisition process: from corporate strategy to pricing,
reimbursement, and market access, the Putnam Associates team
exemplifies relentless problem-solving in the life sciences
industry. Clearsight Advisors is very pleased to have supported
Putnam Associates' strategic and financial goals and we look
forward to watching them grow."
About Clearsight Advisors
Clearsight Advisors is an independent merchant banking firm
dedicated to providing world-class M&A and capital raising
solutions exclusively to growth-oriented Business Services and
Technology companies. Clearsight combines deep market insights
across software, services and data. Clearsight Capital Advisors,
Inc., a wholly owned subsidiary, is a registered member of FINRA
& SIPC.
Contact
Cortney McCoy,
Clearsight Advisors
703-672-3390
cmccoy@clearsightadvisors.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/clearsight-advises-putnam-associates-in-its-acquisition-by-udg-healthcare-plc-300856083.html
SOURCE Clearsight Advisors, Inc.